Showing 1130 – 1140 of 1307 results
-
Costco Wholesale Corporation Initiation
William Blair initiated research coverage of Costco Wholesale Corporation (COST $498.65), a big-box retailer offering its membership base exclusive access to discounted prices across groceries, fresh food, general merchandise, services, and gasoline.
-
Autodesk Inc Initiation
William Blair initiated research coverage of Autodesk, Inc. (ADSK $196.31), a leading enterprise software provider of design, planning, and execution tools for the manufacturing; architecture, engineering, and construction (AEC); and media and entertainment end-markets.
-
Nayax Ltd Initiation
William Blair initiated research coverage of Nayax Ltd. (NYAX $16.56), a leading provider of solutions to the unattended retail vertical (e.g., vending, amusement, kiosks).
-
BellRing Brands Inc Initiation
William Blair initiated research coverage of BellRing Brands, Inc. (BRBR $35.84), a leading provider of branded nutrition products, ready-to-drink protein shakes, and protein powders.
-
Hansa Biopharma AB Initiation
William Blair initiated research coverage of Hansa Biopharma AB (HNSA SEK 47.06), a biotechnology company focused on the development of the immunoglobin G (IgG)-cleaving enzyme imlifidase for serious diseases driven by IgG antibodies.
-
InterDigital Inc Initiation
William Blair initiated research coverage of InterDigital, Inc. (IDCC $68.21), a research-and-development company that designs and develops wireless, visual, and other related technologies that enable connectivity and enhance immersive experiences across various communications and entertainment products.
-
Cutera Inc Initiation
William Blair initiated research coverage of Cutera, Inc. (CUTR $34.21), a leading global aesthetic device company with a comprehensive product portfolio and a global distribution footprint.
-
Jack Henry and Associates Inc Initiation
William Blair initiated research coverage of Jack Henry & Associates, Inc. (JKHY $178.20), an established financial technology company that provides core account processing, complementary solutions, and payments solutions to banks and credit unions in the United States.
-
Neumora Therapeutics Inc Initiation
William Blair initiated research coverage of Neumora Therapeutics, Inc. (NMRA $12.14), a company focused on developing novel therapies for high-unmet-need indications in psychiatry and neurodegenerative diseases.
-
RayzeBio Inc Initiation
William Blair initiated research coverage of RayzeBio, Inc. (RYZB $19.23), a clinical-stage radiopharmaceuticals company with actinium-225-based lead program RYZ101 in a Phase III trial in neuroendocrine tumors (NETs) and Phase Ib study in small-cell lung cancer (SCLC).